行情

QLGN

QLGN

里特制药
NASDAQ

实时行情|Nasdaq Last Sale

0.7901
-0.0854
-9.75%
交易中 15:56 01/27 EST
开盘
0.8800
昨收
0.8755
最高
0.8988
最低
0.7901
成交量
64.16万
成交额
--
52周最高
4.434
52周最低
0.7901
市值
2,788.07万
市盈率(TTM)
-5.4005
分时
5日
1月
3月
1年
5年
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Anixa Biosciences (NASDAQ:ANIX) stock moved upwards by 9.1% to $3.35 during Tuesday's after-market session. The company's market cap stands at $100.9 million.
Benzinga · 1天前
Qualigen Therapeutics Reports Secured Global Rights To G4-Selective Transcription Inhibitors From University College London To Develop As Cancer Therapeutics, No Terms Disclosed
Preclinical Therapeutic Program to Be Initially Focused on Pancreatic Cancer CARLSBAD, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN), a biotechnology company focused on developing
Benzinga · 01/18 14:17
Qualigen Therapeutics 获得伦敦大学学院 G4 选择性转录抑制剂的全球权利,以发展为癌症治疗药物
Preclinical Therapeutic Program to Be Initially Focused on Pancreatic Cancer CARLSBAD, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing treatments for adult and pediatric ca...
GlobeNewswire · 01/18 14:15
5 Short Squeeze Candidates To Watch: Biofrontera Rejoins And Tops List, 2 New Names Enter Leaderboard
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYSE: GME) and AMC Entertainment Holdings (NYSE: AMC) are two high-profile examples of short squee
Benzinga · 2021/12/27 14:28
ZEV, GP and NES among mid-day movers
Gainers: Zhangmen Education (NYSE:ZME) +474%. 22nd Century Group (NASDAQ:XXII) +49%. Pasithea Therapeutics (NASDAQ:KTTA) +36%. Theseus Pharmaceuticals (NASDAQ:THRX) +32%. Qualigen Therapeutics (NASDAQ:QLGN) +32%. Allakos (NASDAQ:ALLK) +27%. REE Automotive ...
Seekingalpha · 2021/12/23 17:30
Qualigen Shares Spike To Session High, Now Up 18% Following Seeking Alpha Blog Post From Contributor Biotechlab '$QLGN Valuation Is $9.00 Per Share. Revenues Increase 38% Year Over Year.'
https://seekingalpha.com/instablog/2694641-biotechlab/5678510-qlgn-valuation-is-9_00-per-share-revenues-increase-38-percent-year-over-year
Benzinga · 2021/12/23 15:31
BRIEF-Qualigen Therapeutics Promotes Amy Broidrick To President
reuters.com · 2021/12/14 14:24
Qualigen Therapeutics Announces $8.82M Offering
 Qualigen Therapeutics, Inc. (NASDAQ:QLGN), a biotechnology company focused on developing novel therapeutic products for the treatment of cancer, as well as maintaining and expanding its flagship
Benzinga · 2021/11/29 20:51
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解QLGN最新的财务预测,通过QLGN每股收益,每股净资产,每股现金流等数据分析里特制药近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
100.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测QLGN价格均价为7.75,最高价位9.00,最低价为6.50。
最高9.00
均价7.75
最低6.50
现价0.7901
EPS
实际EPS
预期EPS
0.050.300.560.81
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
机构持股
总机构数: 40
机构持股: 315.59万
持股比例: 8.94%
总股本: 3,528.75万
类型机构数股数
增持
5
23.17万
建仓
6
30.16万
减持
6
3.31万
平仓
5
17.49万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
-2.88%
制药与医学研究
+0.44%
高管信息
Chairman/Chief Executive Officer/Director
Michael Poirier
President/Director
Amy Broidrick
Chief Financial Officer/Vice President - Finance
Christopher Lotz
Chief Operating Officer/Vice President
Shishir Sinha
Senior Vice President
Tariq Arshad
Chief Scientific Officer/Vice President - Research & Development
Wajdi Abdul-Ahad
Director
Ira Ritter
Independent Director
Richard David
Independent Director
Sidney Emery
Independent Director
Matthew Korenberg
Independent Director
Kurt Kruger
暂无数据
QLGN 简况
Qualigen Therapeutics Inc是一家专注于开发治疗癌症和传染病疗法的生物技术公司。该公司的癌症治疗线包括QN-247、RAS-F和STARS。QN-247是一种脱氧核糖核酸(DNA)包覆的金纳米粒子癌症候选药物,用于靶向各种类型的癌症。QN-247是一种纳米粒子涂层技术,类似于血液检测诊断产品中使用的核心纳米粒子涂层技术。QN-165是一种治疗病毒性传染病的候选药物。RAS-F是大鼠肉瘤病毒(RAS)癌基因蛋白-蛋白相互作用抑制剂小分子家族,用于防止突变的RAS基因蛋白与其效应蛋白结合并防止结合性肿瘤生长,尤其是在胰腺癌、结肠直肠癌和肺癌中。STARS是一种基于DNA/RNA的治疗设备候选产品,用于从循环血液中去除精确靶向的肿瘤产生和病毒化合物。

微牛提供Qualigen Therapeutics Inc(NASDAQ-QLGN)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的QLGN股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易QLGN股票基本功能。